• Japanese
  • Korean
  • Chinese
Cover Image

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013

Abstract

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013" provides data on the Nonmelanomatous Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonmelanomatous Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonmelanomatous Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

TOC

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Nonmelanomatous Skin Cancer 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Clinical Trials by G7 Nations 13
  • Clinical Trials in G7 Nations by Trial Status 14
  • Clinical Trials by Phase 15
  • In Progress Trials by Phase 16
  • Clinical Trials by Trial Status 17
  • Unaccomplished Trials of Nonmelanomatous Skin Cancer 18
  • Subjects Recruited Over a Period of Time 20
  • Prominent Sponsors 21
  • Top Companies Participating in Nonmelanomatous Skin Cancer Therapeutics Clinical Trials 22
  • Prominent Drug Comparison 23
  • Clinical Trial Profiles 24
  • Clinical Trial Overview of Top Companies 24
  • ZBC Multicare 24
  • Clinical Trial Overview of ZBC Multicare 24
  • PharmaQest Pty. Ltd. 25
  • Clinical Trial Overview of PharmaQest Pty. Ltd. 25
  • Genextra S.p.a. 26
  • Clinical Trial Overview of Genextra S.p.a. 26
  • Healthpoint Biotherapeutics 27
  • Clinical Trial Overview of Healthpoint Biotherapeutics 27
  • Pfizer Inc. 28
  • Clinical Trial Overview of Pfizer Inc. 28
  • Galderma S.A. 29
  • Clinical Trial Overview of Galderma S.A. 29
  • Clinical Trial Overview of Top Institutes / Government 30
  • National Cancer Institute 30
  • Clinical Trial Overview of National Cancer Institute 30
  • Roswell Park Cancer Institute 31
  • Clinical Trial Overview of Roswell Park Cancer Institute 31
  • The University of Arizona 32
  • Clinical Trial Overview of The University of Arizona 32
  • The University of Sydney 33
  • Clinical Trial Overview of The University of Sydney 33
  • The University of Chicago 34
  • Clinical Trial Overview of The University of Chicago 34
  • The Cleveland Clinic 35
  • Clinical Trial Overview of The Cleveland Clinic 35
  • Baylor College of Medicine 36
  • Clinical Trial Overview of Baylor College of Medicine 36
  • North Central Cancer Treatment Group 37
  • Clinical Trial Overview of North Central Cancer Treatment Group 37
  • The Medical University of Graz 38
  • Clinical Trial Overview of The Medical University of Graz 38
  • Northwestern University 39
  • Clinical Trial Overview of Northwestern University 39
  • University of Massachusetts 40
  • Clinical Trial Overview of University of Massachusetts 40
  • Case Comprehensive Cancer Center 41
  • Clinical Trial Overview of Case Comprehensive Cancer Center 41
  • Oregon Health and Science University 42
  • Clinical Trial Overview of Oregon Health and Science University 42
  • Rigshospitalet 43
  • Clinical Trial Overview of Rigshospitalet 43
  • University of California, San Diego 44
  • Clinical Trial Overview of University of California, San Diego 44
  • Massachusetts General Hospital 45
  • Clinical Trial Overview of Massachusetts General Hospital 45
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases 46
  • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 46
  • University of Alabama at Birmingham 47
  • Clinical Trial Overview of University of Alabama at Birmingham 47
  • University of Wisconsin Madison 48
  • Clinical Trial Overview of University of Wisconsin Madison 48
  • University of California, Irvine 49
  • Clinical Trial Overview of University of California, Irvine 49
  • Five Key Clinical Profiles 50

Appendix 69

  • Abbreviations 69
  • Definitions 69
  • Research Methodology 70
  • Secondary Research 70
  • About GlobalData 71
  • Contact Us 71
  • Disclaimer 71
  • Source 72

List of Tables

List of Tables

  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 13
  • Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 15
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 16
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 17
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 18
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 19
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 22
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZBC Multicare, 2013* 24
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaQest Pty. Ltd., 2013* 25
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2013* 26
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics, 2013* 27
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 28
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2013* 29
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 30
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2013* 31
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2013* 32
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2013* 33
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 34
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 35
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 36
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2013* 37
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 38
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 39
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 40
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013* 41
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 42
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2013* 43
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 44
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 45
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2013* 46
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 47
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 48
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2013* 49

List of Figures

List of Figures

  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 13
  • Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 15
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 16
  • Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 17
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 22
  • Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
  • GlobalData Methodology 70
Show More
Pricing